These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13378399)

  • 41. [Serous effusions].
    Davidson B; Berner A
    Tidsskr Nor Laegeforen; 2000 Jan; 120(3):367-72. PubMed ID: 10827531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioactive gold in treatment of malignant effusion.
    LEHMAN J
    Miss Valley Med J; 1954 Nov; 76(6):238. PubMed ID: 13213871
    [No Abstract]   [Full Text] [Related]  

  • 44. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cytological diagnosis of cancer in serous effusions.
    Johnson WD
    Acta Cytol; 1966; 10(3):161-72. PubMed ID: 5227366
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of gold and silver-coated radioactive gold colloids in the palliation of ascites and pleural effusions.
    HAHN PF; MENEELY GR; CAROTHERS EL
    Br J Radiol; 1958 May; 31(365):240-5. PubMed ID: 13523154
    [No Abstract]   [Full Text] [Related]  

  • 47. Radioactive gold in malignant effusions.
    WALTER J
    Proc R Soc Med; 1953 Jun; 46(6):466-71. PubMed ID: 13074194
    [No Abstract]   [Full Text] [Related]  

  • 48. A histocytological study of effusions. I. Effusions not associated with malignant tumors.
    LUSE SA; REAGAN JW
    Cancer; 1954 Nov; 7(6):1155-66. PubMed ID: 13209515
    [No Abstract]   [Full Text] [Related]  

  • 49. A histocytological study of effusions. II. Effusions associated with malignant tumors.
    LUSE SA; REAGAN JW
    Cancer; 1954 Nov; 7(6):1167-81. PubMed ID: 13209516
    [No Abstract]   [Full Text] [Related]  

  • 50. Intracavitary administration of radioactive colloidal gold (Au 198) for the treatment of malignant effusions; a report of thirty-one cases and an appraisal of results.
    COPELAND BE; OSBORNE MP
    N Engl J Med; 1956 Dec; 255(24):1122-8. PubMed ID: 13378625
    [No Abstract]   [Full Text] [Related]  

  • 51. [Radiochemotherapy of serous effusions of neoplastic origin].
    Malaspina A; Nuvolone U; Savino G
    Radiobiol Radioter Fis Med; 1968; 23(1):52-64. PubMed ID: 5745146
    [No Abstract]   [Full Text] [Related]  

  • 52. Radioactive gold in malignant effusions.
    MILLAR O; MACDONALD JC
    Can Med Assoc J; 1956 May; 74(10):783-8. PubMed ID: 13316667
    [No Abstract]   [Full Text] [Related]  

  • 53. Histamine levels in serous effusions.
    Chawla SN; Abdullah AK; Singhal KC; Kumar S
    Indian J Med Res; 1976 Jan; 64(1):48-56. PubMed ID: 1270101
    [No Abstract]   [Full Text] [Related]  

  • 54. Radioactive isotopes in management of carcinomatosis of serous body cavities.
    KENT EM; MOSES C; FORD WB; KUTZ ER; GEORGE RS
    AMA Arch Intern Med; 1954 Sep; 94(3):334-40. PubMed ID: 13196715
    [No Abstract]   [Full Text] [Related]  

  • 55. [Differentiation of serous effusions by their fibrinolytic activity].
    BACIU I; CUCUIANU M
    Med Interna (Bucur); 1961 Feb; 13():237-48. PubMed ID: 13685673
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pathological protein permeability. I. Protein bodies of serous effusions].
    FISCHER A; JAKAB M; ROHNY S
    Acta Med Acad Sci Hung; 1958; 11(3):373-9. PubMed ID: 13544845
    [No Abstract]   [Full Text] [Related]  

  • 57. [Value of the determination of lactic dehydrase in the etiological diagnosis of serous effusions].
    RYSER H; BOREL C; FREI J; CSANK I; VANNOTTI A
    Helv Med Acta; 1958 Oct; 25(4):407-9. PubMed ID: 13610218
    [No Abstract]   [Full Text] [Related]  

  • 58. Diagnostic value of p53 protein and flow cytometric DNA analysis in the study of serous effusions.
    Lee JS; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1997; 41(6):1719-25. PubMed ID: 9390131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of p53 protein in the study of serous effusions.
    Zoppi JA; Pellicer EM; Sundblad AS
    Acta Cytol; 1995; 39(4):721-4. PubMed ID: 7631546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of immunohistochemistry in the differential diagnosis of serous effusions.
    Cangi MG; Pecciarini L; Doglioni C
    Adv Clin Path; 2000 Oct; 4(4):183-5. PubMed ID: 11436153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.